LAPUROON Aurora Super

Product Overview

LAPUROON Aurora Super is a South Korean PDRN-based professional skin booster developed by ExoCoBio Co., Ltd. The formulation contains 2% polydeoxyribonucleotide (PDRN) and 1% hyaluronic acid (HA), combined with additional skin-conditioning ingredients, including peptides, amino acids, vitamins, minerals, and coenzymes. Aurora Super is the intensive formulation within the LAPUROON Aurora collection and is supplied in two 2.5 mL pre-filled syringes, providing 5 mL per box.

LAPUROON Aurora Super is positioned for professional aesthetic skincare applications involving skin hydration, texture, and overall skin conditioning. Its formulation combines the water-binding characteristics of HA with PDRN, a DNA-derived ingredient investigated for its involvement in tissue-repair and cellular-maintenance pathways.

Developed using the brand's Neo-PDRN formulation concept, Aurora Super combines PDRN with complementary ingredients in a multi-component skin booster. Compared with LAPUROON Aurora Vivid, Aurora Super contains a tenfold higher declared PDRN concentration while maintaining the same 1% HA concentration.

This product page provides professional buyers with information about LAPUROON Aurora Super's composition, concentrations, packaging, ingredient characteristics, and regulatory considerations.

Key Features

• 2% PDRN Concentration: Contains 2% polydeoxyribonucleotide, equivalent to 20 mg/mL when expressed as a weight-per-volume concentration, distinguishing Aurora Super from the lower-concentration Aurora Vivid formulation.
• 1% Hyaluronic Acid: Formulated with 1% HA, equivalent to 10 mg/mL, providing a hydrophilic ingredient associated with moisture retention and skin hydration.
• Neo-PDRN Formulation Concept: Combines PDRN with additional active ingredients under the LAPUROON brand's proprietary formulation concept.
• Multi-Ingredient Skin Conditioning: Incorporates peptides, amino acids, vitamins, minerals, mannitol, and coenzymes alongside its principal PDRN and HA components.
• 2.5 mL Pre-Filled Syringes: The documented standard packaging contains two 2.5 mL syringes, providing a total nominal volume of 5 mL per box.

Composition & Specifications

LAPUROON Aurora Super combines sodium DNA (PDRN) and hyaluronic acid as its principal identified ingredients. Official LAPUROON product documentation specifies 2% PDRN and 1% HA for the Aurora Super formulation.

The product also incorporates several categories of complementary skin-conditioning ingredients. While their presence is described in brand documentation, the quantitative concentration of each supplementary ingredient is not fully disclosed in the publicly available specifications.

Polydeoxyribonucleotide (PDRN)

PDRN is a DNA-derived polymer consisting of deoxyribonucleotide sequences. In cosmetic ingredient declarations, PDRN-containing materials are commonly identified as sodium DNA.

Experimental research involving selected PDRN preparations has investigated biological processes associated with tissue repair, inflammation regulation, fibroblast activity, and extracellular matrix maintenance.

LAPUROON Aurora Super contains 2% PDRN, corresponding to a nominal concentration of 20 mg/mL. This is ten times the declared PDRN concentration of LAPUROON Aurora Vivid, which contains 0.2%.

Hyaluronic Acid (HA)

Hyaluronic acid is a naturally occurring glycosaminoglycan found in the extracellular matrix of human connective tissues. Its hydrophilic molecular structure allows it to associate with water and contribute to tissue hydration and viscoelasticity.

LAPUROON Aurora Super contains 1% HA, equivalent to 10 mg/mL. This is the same declared HA concentration as Aurora Vivid.

Peptides and Amino Acids

Peptides are short chains of amino acids that may contribute to biological signaling and structural processes depending on their molecular sequences. Amino acids serve as building blocks for proteins and participate in numerous cellular metabolic pathways.

Published ingredient information for LAPUROON Aurora Super identifies multiple peptides and amino acids as components of its broader formulation.

Vitamins, Minerals, and Additional Components

The formulation includes additional ingredients categorized as vitamins, minerals, coenzymes, and skin-conditioning agents.

Brand documentation also describes components such as glutathione and growth factor-related peptides. Glutathione is a naturally occurring tripeptide involved in cellular antioxidant defense, while the biological properties of individual peptides depend on their specific structures.

These ingredients contribute to the formulation's multi-component positioning. However, their general biochemical properties do not independently establish clinical antioxidant, anti-aging, or regenerative effects for the finished product.

The declared 2% PDRN and 1% HA concentrations are supported by LAPUROON product documentation. The exact quantitative composition of supplementary ingredients should be verified against the supplied product's official ingredient declaration.

How LAPUROON Aurora Super Works

LAPUROON Aurora Super combines ingredients with different physicochemical and biological characteristics. Its formulation is centered on PDRN and HA, supported by complementary skin-conditioning components.

PDRN and Tissue-Maintenance Pathways

Polydeoxyribonucleotide has been investigated for its potential interactions with biological processes involved in cellular repair and extracellular matrix regulation.

Research involving certain PDRN preparations has described activity associated with adenosine A2A receptor signaling and nucleotide salvage pathways. These mechanisms have been studied in relation to inflammation regulation, cellular proliferation, and tissue remodeling.

Such findings provide a scientific background for PDRN-containing aesthetic formulations. However, the clinical results of studies using other PDRN preparations cannot automatically be attributed to LAPUROON Aurora Super.

Hyaluronic Acid and Moisture Retention

Hyaluronic acid binds water through its hydrophilic molecular structure and plays an important role in the hydration and physical characteristics of biological tissues.

In LAPUROON Aurora Super, the 1% HA component provides moisture-binding properties consistent with the product's positioning as a hydration-focused skin booster.

The actual effects of an HA-containing formulation depend on its molecular characteristics, concentration, formulation environment, and method of application.

Neo-PDRN Formulation Concept

LAPUROON describes Neo-PDRN as a proprietary formulation concept combining PDRN with other active ingredients. The manufacturer associates this combination with improved skin conditioning, hydration, and radiance.

Aurora Super is positioned as the intensive formulation within the Aurora collection because of its higher PDRN concentration.

A higher ingredient concentration does not independently demonstrate superior clinical efficacy, faster absorption, longer treatment duration, or improved safety. Such comparisons require direct product-specific evidence.

The mechanisms described above relate primarily to established ingredient properties and published PDRN research. They do not constitute proof of specific clinical outcomes for the finished Aurora Super formulation.

Aurora Super Formulation Characteristics

LAPUROON Aurora Super is the higher-concentration PDRN formulation in the LAPUROON Aurora collection. Its distinguishing characteristics include 2% PDRN, 1% HA, and a 2.5 mL pre-filled syringe presentation.

• Intensive PDRN Formulation: Contains 2% PDRN compared with the 0.2% concentration found in Aurora Vivid.
• Hydration-Oriented Composition: Includes 1% hyaluronic acid for its water-binding and moisture-retaining characteristics.
• Complementary Ingredients: Combines PDRN and HA with peptides, amino acids, vitamins, minerals, and other skin-conditioning components.
• Pre-Filled Syringe Packaging: Uses a 2.5 mL syringe format, distinguishing Aurora Super from the 5 mL vial presentation of Aurora Vivid.

The manufacturer positions Aurora Super for intensive skincare and Aurora Vivid for milder skin-conditioning applications. These descriptions represent product positioning rather than independently established comparative clinical outcomes.

Aurora Super and Aurora Vivid are separate commercial formulations. Their concentrations, container types, and packaging quantities should not be confused when evaluating product specifications.

Packaging & Product Presentation

LAPUROON Aurora Super is supplied as a liquid formulation in pre-filled syringes. The standard manufacturer-documented packaging contains two syringes with a nominal volume of 2.5 mL each.

The 2.5 mL × 2 syringe configuration is documented in the LAPUROON product catalog and official distributor information. Commercial suppliers may also list individual syringes separately from complete manufacturer boxes.

Verify whether the selected TEOSQUARE option refers to one 2.5 mL syringe or a complete two-syringe box. The pre-filled syringe format does not independently establish authorization for injection or any other invasive application method.

Storage & Handling

LAPUROON Aurora Super should be stored according to the original manufacturer labeling and instructions applicable to the specific supplied product. A definitive numerical storage temperature range has not been established from the publicly available primary product documentation.

• Original Packaging: Keep the product in its original packaging until required for its permitted application.
• Temperature Requirements: Follow the storage temperature indicated on the original product label.
• Environmental Protection: Avoid exposure to conditions that conflict with the manufacturer's storage and handling instructions.
• Packaging Integrity: Inspect the pre-filled syringe, closure, and original packaging for visible damage or leakage.
• Product Traceability: Verify the product name, concentration, batch number, expiration date, and market-specific labeling.

Do not assume refrigerated storage, room-temperature storage, or a specific shelf life without confirming the official labeling. Requirements may differ between commercial presentations and destination markets.

Safety & Regulatory Considerations

LAPUROON Aurora Super is marketed internationally as a professional PDRN skin booster. Its legal product classification, intended application method, and regulatory authorization must be established for the specific supplied presentation and destination country.

The presence of PDRN, hyaluronic acid, peptides, vitamins, and other skin-conditioning ingredients does not independently establish suitability or safety for invasive administration.

Although Aurora Super is supplied in pre-filled syringes, this packaging format does not by itself establish authorization for injection. Application methods must comply with the product's legally permitted intended use and original manufacturer instructions.

Individual formulation components may cause irritation, sensitivity, or hypersensitivity in susceptible individuals. The safety of a multi-ingredient product depends on its complete composition, manufacturing controls, exposure conditions, and intended application.

Where an invasive procedure is legally authorized, additional risks may include localized inflammation, infection, swelling, bruising, and other procedure-related complications.

The product's higher PDRN concentration should not be interpreted as a guarantee of superior safety, greater clinical effectiveness, faster regeneration, or permanent skin improvement.

Regulatory authorization in one country does not automatically establish approval in another. Professional buyers should verify the product's classification, registration, labeling, and permitted applications before procurement.

This information is intended for professional product identification and comparison. It does not constitute clinical guidance, establish individual suitability, or authorize any treatment method beyond the applicable product labeling.

Frequently Asked Questions